Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 5
1999 2
2000 8
2001 3
2002 8
2003 13
2004 14
2005 20
2006 25
2007 46
2008 92
2009 77
2010 18
2011 21
2012 17
2013 14
2014 19
2015 19
2016 17
2017 7
2018 12
2019 6
2020 15
2021 8
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19424051

444 results

Results by year

Filters applied: . Clear all
Page 1
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, Foit C, Calhoun D, Bernstein B, Hanna GJ. Cameron DW, et al. J Antimicrob Chemother. 2007 May;59(5):957-63. doi: 10.1093/jac/dkm029. Epub 2007 Mar 9. J Antimicrob Chemother. 2007. PMID: 17350990 Clinical Trial.
Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.
Frange P, Briand N, Avettand-fenoel V, Veber F, Moshous D, Mahlaoui N, Rouzioux C, Blanche S, Chaix ML. Frange P, et al. Pediatr Infect Dis J. 2011 Aug;30(8):684-8. doi: 10.1097/INF.0b013e31821752d6. Pediatr Infect Dis J. 2011. PMID: 21427626
Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.
van Vonderen MG, Blümer RM, Hassink EA, Sutinen J, Ackermans MT, van Agtmael MA, Yki-Jarvinen H, Danner SA, Serlie MJ, Sauerwein HP, Reiss P. van Vonderen MG, et al. J Acquir Immune Defic Syndr. 2010 Feb;53(2):186-93. doi: 10.1097/QAI.0b013e3181c190f4. J Acquir Immune Defic Syndr. 2010. PMID: 19898246 Clinical Trial.
444 results